A
Arcturus Therapeutics develops and commercializes messenger RNA (mRNA) medicines and vaccines. The company utilizes proprietary technologies like STARR® and the LUNAR® delivery mechanism to create novel therapeutic and prophylactic agents. Their pipeline includes candidates addressing conditions such as Cystic Fibrosis and Ornithine Transcarbamylase (OTC) deficiency.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Arcturus Therapeutics develops and commercializes messenger RNA (mRNA) medicines and vaccines. The company utilizes proprietary technologies like STARR® and the LUNAR® delivery mechanism to create novel therapeutic and prophylactic agents. Their pipeline includes candidates addressing conditions such as Cystic Fibrosis and Ornithine Transcarbamylase (OTC) deficiency.